The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease.
A somatostatin deficit occurs in the cerebral cortex of Alzheimer's disease patients without a major loss in somatostatin-containing neurons. This deficit could be related to a reduction in the rate of proteolytic processing of peptide precursors. Since the two proprotein convertases (PC)1 and PC2 are responsible for the processing of neuropeptide precursors directed to the regulated secretory pathway, we examined whether they are involved first in the proteolytic processing of prosomatostatin in mouse and human brain and secondly in somatostatin defect associated with Alzheimer's disease. By size exclusion chromatography, the cleavage of prosomatostatin to somatostatin-14 is almost totally abolished in the cortex of PC2 null mice, while the proportions of prosomatostatin and somatostatin-28 are increased. By immunohistochemistry, PC1 and PC2 were localized in many neuronal elements in human frontal and temporal cortex. The convertases levels were quantified by Western blot, as well as the protein 7B2 which is required for the production of active PC2. No significant change in PC1 levels was observed in Alzheimer's disease. In contrast, a marked decrease in the ratio of the PC2 precursor to the total enzymatic pool was observed in the frontal cortex of Alzheimer patients. This decrease coincides with an increase in the binding protein 7B2. However, the content and enzymatic activity of the PC2 mature form were similar in Alzheimer patients and controls. Therefore, the cortical somatostatin defect is not due to convertase alteration occuring during Alzheimer's disease. Further studies will be needed to assess the mechanisms involved in somatostatin deficiency in Alzheimer's disease.
Winsky-Sommerer
R
R
INSERM U549, IFR Broca-Sainte Anne, Centre Paul Broca, 2 ter rue d'Alésia, 75014 Paris, France.
Grouselle
D
D
Rougeot
C
C
Laurent
V
V
David
J-P
JP
Delacourte
A
A
Dournaud
P
P
Seidah
N G
NG
Lindberg
I
I
Trottier
S
S
Epelbaum
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D000704:Analysis of Variance; D000818:Animals; D002540:Cerebral Cortex / Q000201:enzymology / Q000473:pathology; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D045706:Proprotein Convertase 2 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism*; D011499:Protein Processing, Post-Translational / Q000235:genetics / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000096:biosynthesis* / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*
D011498:Protein Precursors; D013004:Somatostatin; C028456:prosomatostatin; D045706:Proprotein Convertase 2